MGTX

7.9801.97%
RK

Robert K. Zeldin

Chief Medical Officer

Dr. Robert K. Zeldin, M.D. FAAAAI, serves as Chief Medical Officer at MeiraGTx Holdings plc since August 2020. He served as Chief Medical Officer at Immunovant, Inc. since July 2019 until April 2020. Dr. Zeldin served as Chief Medical Officer of Acceleron Pharma Inc. since June 2018 until April 5, 2019. Dr. Zeldin has more than two decades of clinical, regulatory. He was Chief Medical Officer at Ablynx NV since December 1, 2015 until June 2018. From November 1997 to March 2005, Dr. Zeldin held increasingly strategic roles in worldwide regulatory affairs and clinical development at Merck & Co., Inc. He was responsible for the Medical, Regulatory, Pharmacovigilance, Clinical Operations, Biostatistics, and Data Management functions and led a team of 60. He joined Ablynx from French pharmaceutical firm Stallergenes SA, where he was Senior Vice President and Head of Global Clinical Development from January 2011 to November 2015. From March 2005 to April 2010, he worked at Novartis Pharmaceuticals, first as Executive Medical Director and later as Vice President and U.S. Medical Franchise Head, Respiratory and Dermatology. Dr. Zeldin’s career in industry began at Merck, where he worked in strategic roles in worldwide regulatory affairs and clinical development, rising to the position of Senior Director of Clinical Development with responsibility for products in the respiratory, cardiovascular, and infectious disease therapeutic areas. Prior to his work in industry, Dr. Zeldin served as a Medical Officer at the U.S. Food & Drug Administration’s Center for Biologics Evaluation and Research, assessing efficacy and safety data from the clinical development of allergy-related therapies, vaccines, and orphan products. He also worked in clinical practice treating patients with allergic, asthmatic, and immunologic disorders. His postdoctoral training included Residency in Internal Medicine at University Health Center of Pittsburgh and Fellowship in Allergy and Clinical Immunology at Johns Hopkins University School of Medicine. He holds a B.A. in Psychology with honors from Johns Hopkins University and an M.D. from Tufts University School of Medicine.

Positions